Core Viewpoint - Hendi Pharmaceutical (301211.SZ) announced plans for significant share reductions by major shareholders, indicating potential changes in ownership structure and market sentiment [1] Shareholder Reduction Plans - Shareholder Jingmen Ningkang Enterprise Management Center (Limited Partnership) plans to reduce its holdings by up to 4.176 million shares, representing 1% of the company's total share capital, within three months after the announcement [1] - Shareholder Jingmen Beikang Enterprise Management Center (Limited Partnership) intends to reduce its holdings by up to 1.392 million shares, accounting for 0.33% of the company's total share capital, within the same timeframe [1] - Shareholder Lei Xiaoyan plans to reduce her holdings by up to 4.176 million shares, also representing 1% of the company's total share capital, within three months following the announcement [1]
亨迪药业(301211.SZ)：三股东拟减持合计不超2.33%股份